Mammoth Biosciences Stock
Mammoth Biosciences is a biotechnology company based in Brisbane, California, that focuses on developing diagnostic tests and therapies using advanced CRISPR technology. Founded in 2017 by notable figures including Nobel laureate Jennifer Doudna, the company aims to leverage its proprietary ultracompact CRISPR systems for various applications, including gene editing and decentralized precision diagnostics.
Sign up for SecondMarket™ to view the market and buy or sell Mammoth Biosciences Stock
Buy + SellMammoth Biosciences Funding
Sign up to gain insights into Mammoth Biosciences funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the DataDate | Financing Round | Amount | Price per share* | Valuation* |
---|---|---|---|---|
Apr 22, 2024 | Series D | 106.69M | ||
Aug 05, 2021 | Series D | 150.00M | ||
May 19, 2020 | Series C | 49.25M | ||
May 19, 2020 | Series C | 747.77K | ||
Feb 24, 2020 | Series B | 36.77M | ||
Feb 24, 2020 | Series B | 7.41M | ||
Feb 25, 2019 | Series A | 4.94M | ||
May 15, 2018 | Series A | 13.16M |
See Mammoth Biosciences Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Mammoth Biosciences Stock Valuation + Share Prices
View real-time Tape D™ data on Mammoth Biosciences stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedMammoth Biosciences Management Team
Co-Founder, CEO, Director
Trevor Martin
Director
Maneesh Jain
Co-founder, Chief Science Officer
Lucas Harrington
Co-founder, Chair of Scientific Advisory Board
Jennifer A. Doudna
Co-Founder, Chief Technology Officer, Director
Janice Chen
Director
Min Cui
Director
Jeff Huber
Director
Jeremy Green
Mammoth Biosciences Major Investors
Verily Life Sciences LLC
Redmile Group
Decheng Capital LLC
Greenspring Associates, Inc
Greenspring Associates, Inc
Foresite Capital
Senator Investment Group
8VC
Plum Alley Co.
Sixth Street Partners
Mayfield Fund
Pacific 8 Ventures
aMoon Fund
NFX